Decoupling Ecological and Pathogenic Roles: Helicobacter pylori as a Gastric Hegemon Maintaining Order or Amplifying
Zhanshan Sam Ma1,2, Katee Li3, Yuting Qiao1
1Computational Biology and Medical Ecology Lab, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China.
Abstract:
Gastric dysbiosis refers to disease-associated alterations in microbial composition and between-individual variability. We postulate that Helicobacter pylori (H. pylori or Hp) exerts a context-dependent ecological effect across the Correa cascade-the histopathological progression from chronic gastritis through atrophic gastritis and intestinal metaplasia to gastric cancer-by constraining microbiome variation when acting alone but amplifying disease-associated divergence as pathology advances. We reanalyzed 756 gastric 16S rRNA gene profiles using Hill-number beta diversity and the Anna Karenina principle across three complementary schemes: (1) comparison of H. pylori infection status within each disease stage (Scheme-I); (2) disease progression in the Hp-negative cohorts, from healthy controls to successive disease stages (Scheme-II); and (3) disease progression in the Hp-positive, from healthy controls to successive disease stages (Scheme-III). We find: H. pylori alone consistently reduced microbiome divergence across disease stages, indicating a homogenizing effect rather than direct induction of dysbiosis. In contrast, progression to gastric cancer was the strongest driver of divergent dysbiosis, even in the absence of the bacterium. Most importantly, the presence of H. pylori caused dysbiotic divergence to emerge in multiple precancerous disease stages. These findings identify H. pylori as a context-dependent ecosystem modifier that maintains order in isolation but amplifies disease-associated dysbiosis.
Related Concept Videos
Gastritis II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

